Category: Health Science
-
![As Australia opens to cannabis, Canntab’s (PILL.C) tech might just claim the box seat]()
As Australia opens to cannabis, Canntab’s (PILL.C) tech might just claim the box seat
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock into space. That’s understandable, to be honest, as North American investors have taken an eye off the island continent and its slow roll to weed legalization…
-
![Heritage Cannabis (CANN.C) Receives Health Canada Export License]()
Heritage Cannabis (CANN.C) Receives Health Canada Export License
Heritage Cannabis (CANN.C) has been granted an export license by Health Canada. The license will permit the Company to export cannabis products to Brazil marking the first-ever license granting the export of CBD products from Canada to Brazil. “We are very pleased to be the first cannabis company in Canada to be granted an export…
-
![Manganese X (MN.V) Subsidiary Receives Positive Preliminary Results on COVID Mitigating HVAC Filtration]()
Manganese X (MN.V) Subsidiary Receives Positive Preliminary Results on COVID Mitigating HVAC Filtration
Manganese X Energy’s (MN.V) wholly-owned subsidiary, Disruptive Battery, and their JV Partner, PureBiotic Air, have received positive preliminary results from their research study, being conducted in conjunction with Virginia State University (VSU). The study included the successful production of the biofilm required for further research and testing on PureBiotic’s HVAC (heating, ventilation, air conditioning) delivery…
-
Sixth Wave (SIXW.C) surges 15% as Polymer Imprint detects SARS-CoV-2 during initial testing
“Molecularly imprinted polymers (MIPs) are synthetic polymers with a predetermined selectivity for a given analyte, or group of structurally related compounds, making them ideal materials to be used in separation processes,” explains Science Direct.
-
![Aequus Pharma (AQS.V) launches Evolve Eyedrops to eye care professionals in Canada]()
Aequus Pharma (AQS.V) launches Evolve Eyedrops to eye care professionals in Canada
Aequus is a $24 million pharmaceutical company focused on developing and commercializing high quality, differentiated products.
-
![Revive Therapeutics (RVV.C) finds $23 million and throws it at their bucillamine clinical studies]()
Revive Therapeutics (RVV.C) finds $23 million and throws it at their bucillamine clinical studies
Revive Therapeutics (RVV.C) provided an update on their Phase 3 clinical trial for bucillamine for COVID-19 today. Primarily, the update’s about funding and more specifically their recent $23 million financing. The company intends to use the monies to fund their aggressive expansion from14 clinical sites to 50 to meet their enrolment requires for the study…
-
That was quick! Xphyto (XPHY.C) orders 9,600 Covid-19 PCR tests – stock up 67% year-to-date
“PCR tests are used to directly detect the presence of an antigen, rather than the presence of the body’s immune response, or antibodies,” states Medical Device Network, “By detecting viral RNA, which will be present in the body before symptoms of the disease are present,” the tests give a powerful early warning system.
-
![Perimeter Medical Imaging AI (PINK.V) technology advances as ACS reports 2.3 million new breast cancer cases]()
Perimeter Medical Imaging AI (PINK.V) technology advances as ACS reports 2.3 million new breast cancer cases
In 25% of Breast Lumpectomy surgeries, cancerous material is left behind. With current technology, the surgeon needs to wait about a week, to see if he’s got all the cancerous material.
-
![Xphyto (XPHY.C) assembles biotech/biz dream-team to launch 25-minute Covid-19 test]()
Xphyto (XPHY.C) assembles biotech/biz dream-team to launch 25-minute Covid-19 test
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports.
-
![Diagnos (ADK.V) A.I. retina analysis creates a powerful early warning system for diabetics]()
Diagnos (ADK.V) A.I. retina analysis creates a powerful early warning system for diabetics
DIAGNOS specialises in early detection of health problems based on its FLAIRE artificial intelligence (AI) platform.
